Related references
Note: Only part of the references are listed.Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1nu mice
Carmen Eicher et al.
LIVER INTERNATIONAL (2012)
A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer
Martijn P. Lolkema et al.
CLINICAL CANCER RESEARCH (2011)
Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
Ryan S. Noyce et al.
PLOS PATHOGENS (2011)
Oncolytic adenovirus treatment of a patient with refractory neuroblastoma
Sari Pesonen et al.
ACTA ONCOLOGICA (2010)
Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study
J. Garcia-Castro et al.
CANCER GENE THERAPY (2010)
Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
Sunil K. Geevarghese et al.
HUMAN GENE THERAPY (2010)
Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells
Jeannine Lacroix et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study
Jozsef Zsiros et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells
Akira Watanabe et al.
JOURNAL OF VIROLOGY (2010)
Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma
Xin Meng et al.
MOLECULAR THERAPY (2010)
Oncolytic virotherapy for advanced liver tumours
Ju-Fang Chang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Protein Kinase PKR Mediates the Apoptosis Induction and Growth Restriction Phenotypes of C Protein-Deficient Measles Virus
Ann M. Toth et al.
JOURNAL OF VIROLOGY (2009)
Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
Giorgio Perilongo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
David H. Kirn et al.
NATURE REVIEWS CANCER (2009)
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response
Anne Gauvrit et al.
CANCER RESEARCH (2008)
A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
Laura Vidal et al.
CLINICAL CANCER RESEARCH (2008)
Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model
Hidemi Toyoda et al.
CANCER RESEARCH (2007)
Engineering oncolytic measles virus to circumvent the intracellular innate immune response
Iana Haralambieva et al.
MOLECULAR THERAPY (2007)
Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma
Hongtao Li et al.
CLINICAL CANCER RESEARCH (2007)
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma
Boris Blechacz et al.
HEPATOLOGY (2006)
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
Cari J. McDonald et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death
Subbiah Elankumaran et al.
JOURNAL OF VIROLOGY (2006)
Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells
L Heinzerling et al.
BLOOD (2005)
Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus type 5 for the treatment of high-risk neuroblastomas in preclinical models
NS Parikh et al.
PEDIATRIC BLOOD & CANCER (2005)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
D Dingli et al.
BLOOD (2004)
Risk-adapted treatment for childhood hepatoblastoma:: final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2
G Perilongo et al.
EUROPEAN JOURNAL OF CANCER (2004)
CD46: A complement regulator and pathogen receptor that mediates links between innate and acquired immune function
S Russell
TISSUE ANTIGENS (2004)
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
BD Anderson et al.
CANCER RESEARCH (2004)
Measles virus receptors: SLAM and CD46
N Dhiman et al.
REVIEWS IN MEDICAL VIROLOGY (2004)
In vivo imaging and tumor therapy with the sodium iodide symporter
D Dingli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Treatment of unresectable and metastatic hepatoblastoma: A pediatric oncology group phase II study
HM Katzenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Pretreatment prognostic factors and treatment results in children with hepatoblastoma -: A report from the German Cooperative Pediatric Liver Tumor Study HB 94
J Fuchs et al.
CANCER (2002)
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides
KW Peng et al.
NATURE MEDICINE (2002)
Systemic therapy of myeloma xenografts by an attenuated measles virus
KW Peng et al.
BLOOD (2001)
Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice
D Grote et al.
BLOOD (2001)
Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage
CL Parks et al.
JOURNAL OF VIROLOGY (2001)
SLAM (CDw150) is a cellular receptor for measles virus
H Tatsuo et al.
NATURE (2000)
Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus
C Servet-Delprat et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
